AAPL   322.75 (+1.46%)
MSFT   183.80 (+1.09%)
FB   231.11 (+0.86%)
GOOGL   1,439.70 (+1.37%)
AMZN   2,436.00 (+1.06%)
CGC   20.92 (+5.13%)
MU   47.85 (-3.24%)
GE   7.06 (-3.16%)
TSLA   817.65 (-0.31%)
AMD   53.38 (+1.21%)
T   31.54 (-0.97%)
ACB   15.97 (+4.31%)
F   5.95 (-1.33%)
DIS   118.50 (-2.49%)
NFLX   421.13 (+0.30%)
BAC   25.27 (-2.73%)
BA   153.46 (+2.64%)
AAPL   322.75 (+1.46%)
MSFT   183.80 (+1.09%)
FB   231.11 (+0.86%)
GOOGL   1,439.70 (+1.37%)
AMZN   2,436.00 (+1.06%)
CGC   20.92 (+5.13%)
MU   47.85 (-3.24%)
GE   7.06 (-3.16%)
TSLA   817.65 (-0.31%)
AMD   53.38 (+1.21%)
T   31.54 (-0.97%)
ACB   15.97 (+4.31%)
F   5.95 (-1.33%)
DIS   118.50 (-2.49%)
NFLX   421.13 (+0.30%)
BAC   25.27 (-2.73%)
BA   153.46 (+2.64%)
AAPL   322.75 (+1.46%)
MSFT   183.80 (+1.09%)
FB   231.11 (+0.86%)
GOOGL   1,439.70 (+1.37%)
AMZN   2,436.00 (+1.06%)
CGC   20.92 (+5.13%)
MU   47.85 (-3.24%)
GE   7.06 (-3.16%)
TSLA   817.65 (-0.31%)
AMD   53.38 (+1.21%)
T   31.54 (-0.97%)
ACB   15.97 (+4.31%)
F   5.95 (-1.33%)
DIS   118.50 (-2.49%)
NFLX   421.13 (+0.30%)
BAC   25.27 (-2.73%)
BA   153.46 (+2.64%)
AAPL   322.75 (+1.46%)
MSFT   183.80 (+1.09%)
FB   231.11 (+0.86%)
GOOGL   1,439.70 (+1.37%)
AMZN   2,436.00 (+1.06%)
CGC   20.92 (+5.13%)
MU   47.85 (-3.24%)
GE   7.06 (-3.16%)
TSLA   817.65 (-0.31%)
AMD   53.38 (+1.21%)
T   31.54 (-0.97%)
ACB   15.97 (+4.31%)
F   5.95 (-1.33%)
DIS   118.50 (-2.49%)
NFLX   421.13 (+0.30%)
BAC   25.27 (-2.73%)
BA   153.46 (+2.64%)
Log in

NASDAQ:AVGRAvinger Stock Price, Forecast & News

$0.33
+0.01 (+2.98 %)
(As of 05/28/2020 01:22 PM ET)
Add
Compare
Today's Range
$0.32
Now: $0.33
$0.34
50-Day Range
$0.28
MA: $0.36
$0.51
52-Week Range
$0.24
Now: $0.33
$5.70
Volume19,223 shs
Average Volume3.39 million shs
Market Capitalization$10.49 million
P/E RatioN/A
Dividend YieldN/A
Beta1.13
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Read More
Avinger logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.32 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.13 million
Book Value$0.14 per share

Profitability

Net Income$-19,450,000.00
Net Margins-211.96%

Miscellaneous

EmployeesN/A
Market Cap$10.49 million
Next Earnings Date7/29/2020 (Estimated)
OptionableNot Optionable

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.

Avinger (NASDAQ:AVGR) Frequently Asked Questions

How has Avinger's stock been impacted by COVID-19 (Coronavirus)?

Avinger's stock was trading at $0.43 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVGR shares have decreased by 22.3% and is now trading at $0.3342. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Avinger?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avinger.

When is Avinger's next earnings date?

Avinger is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Avinger.

How were Avinger's earnings last quarter?

Avinger Inc (NASDAQ:AVGR) released its quarterly earnings data on Wednesday, May, 13th. The medical device company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.06. The medical device company earned $2.26 million during the quarter. Avinger had a negative return on equity of 270.15% and a negative net margin of 211.96%. View Avinger's earnings history.

When did Avinger's stock split? How did Avinger's stock split work?

Avinger shares reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

What guidance has Avinger issued on next quarter's earnings?

Avinger issued an update on its first quarter 2020 After-Hours earnings guidance on Wednesday, April, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.25-2.25 million, compared to the consensus revenue estimate of $2.56 million.

What price target have analysts set for AVGR?

2 equities research analysts have issued 1-year price objectives for Avinger's shares. Their forecasts range from $1.40 to $1.40. On average, they anticipate Avinger's share price to reach $1.40 in the next twelve months. This suggests a possible upside of 318.9% from the stock's current price. View analysts' price targets for Avinger.

Has Avinger been receiving favorable news coverage?

Press coverage about AVGR stock has been trending somewhat positive recently, according to InfoTrie. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avinger earned a daily sentiment score of 1.0 on InfoTrie's scale. They also gave press coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutAvinger.

Who are some of Avinger's key competitors?

What other stocks do shareholders of Avinger own?

Who are Avinger's key executives?

Avinger's management team includes the following people:
  • Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)
  • Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)
  • Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)
  • Mr. Keith Schaefer, Chief Operating Officer
  • Mr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41)

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Perkins Capital Management Inc. (7.52%) and Sabby Management LLC (1.93%). View institutional ownership trends for Avinger.

Which institutional investors are buying Avinger stock?

AVGR stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC, and Perkins Capital Management Inc.. View insider buying and selling activity for Avinger.

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.33.

How big of a company is Avinger?

Avinger has a market capitalization of $10.47 million and generates $9.13 million in revenue each year. The medical device company earns $-19,450,000.00 in net income (profit) each year or ($3.18) on an earnings per share basis.

What is Avinger's official website?

The official website for Avinger is www.avinger.com.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.